Loading…
Cost of the quanta SC+ hemodialysis system for self‐care in the United Kingdom
Introduction New personal hemodialysis systems, such as the quanta SC+, are being developed; these systems are smaller and simpler to use while providing the clearances of conventional systems. Increasing the uptake of lower‐intensity assistance and full self‐care dialysis may provide economic benef...
Saved in:
Published in: | Hemodialysis international 2022-07, Vol.26 (3), p.287-294 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c2754-13cb6d66b3a56115842faf7758cb1f0acdcee4bf93226d67e64cc0518787b5063 |
---|---|
cites | cdi_FETCH-LOGICAL-c2754-13cb6d66b3a56115842faf7758cb1f0acdcee4bf93226d67e64cc0518787b5063 |
container_end_page | 294 |
container_issue | 3 |
container_start_page | 287 |
container_title | Hemodialysis international |
container_volume | 26 |
creator | Ferguson, Thomas W. Harper, Gerard D. Milad, John E. Komenda, Paul V. J. |
description | Introduction
New personal hemodialysis systems, such as the quanta SC+, are being developed; these systems are smaller and simpler to use while providing the clearances of conventional systems. Increasing the uptake of lower‐intensity assistance and full self‐care dialysis may provide economic benefits to the public health payer. In the United Kingdom, most hemodialysis patients currently receive facility‐based dialysis costing more than £36,350 per year including patient transport. As such, we aimed to describe the annual costs of using the SC+ hemodialysis system in the United Kingdom for 3×‐weekly and 3.5×‐weekly dialysis regimens, for self‐care hemodialysis provided both in‐center and at home.
Methods
We applied a cost minimization approach. Costs for human resources, equipment, and consumables were sourced from the dialysis machine developer (Quanta Dialysis Technologies) based upon discussions with dialysis providers. Facility overhead expenses and transport costs were taken from a review of the literature.
Findings
Annual costs associated with the use of the SC+ hemodialysis system were estimated to be £26,642 for hemodialysis provided 3× weekly as home self‐care; £30,235 for hemodialysis provided 3× weekly as self‐care in‐center; £29,866 for hemodialysis provided 3.5× weekly as home self‐care; and £36,185 for hemodialysis provided 3.5× weekly as self‐care in‐center.
Discussion
We found that the SC+ hemodialysis system offers improved cost‐effectiveness for both 3×‐weekly and 3.5×‐weekly self‐care dialysis performed at home or as self‐care in‐center versus fully assisted dialysis provided 3× weekly with conventional machines in facilities. |
doi_str_mv | 10.1111/hdi.12994 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2618502305</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2618502305</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2754-13cb6d66b3a56115842faf7758cb1f0acdcee4bf93226d67e64cc0518787b5063</originalsourceid><addsrcrecordid>eNp1kEtOwzAQhi0EolBYcAHkJQiltR3bSZYoPFpRCSTo2nIcmxrl0caJUHYcgTNyEkxT2DHSaGbxzafRD8AZRhPsa7rK7QSTJKF74AgzSgIasXjf7zQhQcRCNgLHzr0hRDBC_BCMQoYQ9n0EntLatbA2sF1puOlk1Ur4nF7BlS7r3Mqid9ZB17tWl9DUDXS6MF8fn0o2Gtpqe7WsbKtz-GCr17wuT8CBkYXTp7s5Bsu725d0Fiwe7-fp9SJQJGI0wKHKeM55FkrGMWYxJUaayP-tMmyQVLnSmmYmCQnxXKQ5VQoxHEdxlDHEwzG4GLzrpt502rWitE7popCVrjsnCMcxQyREzKOXA6qa2rlGG7FubCmbXmAkfgIUPkCxDdCz5zttl5U6_yN_E_PAdADebaH7_01idjMflN8brXmX</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2618502305</pqid></control><display><type>article</type><title>Cost of the quanta SC+ hemodialysis system for self‐care in the United Kingdom</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Ferguson, Thomas W. ; Harper, Gerard D. ; Milad, John E. ; Komenda, Paul V. J.</creator><creatorcontrib>Ferguson, Thomas W. ; Harper, Gerard D. ; Milad, John E. ; Komenda, Paul V. J.</creatorcontrib><description>Introduction
New personal hemodialysis systems, such as the quanta SC+, are being developed; these systems are smaller and simpler to use while providing the clearances of conventional systems. Increasing the uptake of lower‐intensity assistance and full self‐care dialysis may provide economic benefits to the public health payer. In the United Kingdom, most hemodialysis patients currently receive facility‐based dialysis costing more than £36,350 per year including patient transport. As such, we aimed to describe the annual costs of using the SC+ hemodialysis system in the United Kingdom for 3×‐weekly and 3.5×‐weekly dialysis regimens, for self‐care hemodialysis provided both in‐center and at home.
Methods
We applied a cost minimization approach. Costs for human resources, equipment, and consumables were sourced from the dialysis machine developer (Quanta Dialysis Technologies) based upon discussions with dialysis providers. Facility overhead expenses and transport costs were taken from a review of the literature.
Findings
Annual costs associated with the use of the SC+ hemodialysis system were estimated to be £26,642 for hemodialysis provided 3× weekly as home self‐care; £30,235 for hemodialysis provided 3× weekly as self‐care in‐center; £29,866 for hemodialysis provided 3.5× weekly as home self‐care; and £36,185 for hemodialysis provided 3.5× weekly as self‐care in‐center.
Discussion
We found that the SC+ hemodialysis system offers improved cost‐effectiveness for both 3×‐weekly and 3.5×‐weekly self‐care dialysis performed at home or as self‐care in‐center versus fully assisted dialysis provided 3× weekly with conventional machines in facilities.</description><identifier>ISSN: 1492-7535</identifier><identifier>ISSN: 1542-4758</identifier><identifier>EISSN: 1542-4758</identifier><identifier>DOI: 10.1111/hdi.12994</identifier><identifier>PMID: 35001500</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley & Sons, Inc</publisher><subject>cost effectiveness ; Cost-Benefit Analysis ; dialysis ; economic analysis ; hemodialysis ; Hemodialysis, Home ; Humans ; Kidney Failure, Chronic - therapy ; Peritoneal Dialysis ; Renal Dialysis ; Self Care</subject><ispartof>Hemodialysis international, 2022-07, Vol.26 (3), p.287-294</ispartof><rights>2022 The Authors. published by Wiley Periodicals LLC on behalf of International Society for Hemodialysis.</rights><rights>2022 The Authors. Hemodialysis International published by Wiley Periodicals LLC on behalf of International Society for Hemodialysis.</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2754-13cb6d66b3a56115842faf7758cb1f0acdcee4bf93226d67e64cc0518787b5063</citedby><cites>FETCH-LOGICAL-c2754-13cb6d66b3a56115842faf7758cb1f0acdcee4bf93226d67e64cc0518787b5063</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35001500$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ferguson, Thomas W.</creatorcontrib><creatorcontrib>Harper, Gerard D.</creatorcontrib><creatorcontrib>Milad, John E.</creatorcontrib><creatorcontrib>Komenda, Paul V. J.</creatorcontrib><title>Cost of the quanta SC+ hemodialysis system for self‐care in the United Kingdom</title><title>Hemodialysis international</title><addtitle>Hemodial Int</addtitle><description>Introduction
New personal hemodialysis systems, such as the quanta SC+, are being developed; these systems are smaller and simpler to use while providing the clearances of conventional systems. Increasing the uptake of lower‐intensity assistance and full self‐care dialysis may provide economic benefits to the public health payer. In the United Kingdom, most hemodialysis patients currently receive facility‐based dialysis costing more than £36,350 per year including patient transport. As such, we aimed to describe the annual costs of using the SC+ hemodialysis system in the United Kingdom for 3×‐weekly and 3.5×‐weekly dialysis regimens, for self‐care hemodialysis provided both in‐center and at home.
Methods
We applied a cost minimization approach. Costs for human resources, equipment, and consumables were sourced from the dialysis machine developer (Quanta Dialysis Technologies) based upon discussions with dialysis providers. Facility overhead expenses and transport costs were taken from a review of the literature.
Findings
Annual costs associated with the use of the SC+ hemodialysis system were estimated to be £26,642 for hemodialysis provided 3× weekly as home self‐care; £30,235 for hemodialysis provided 3× weekly as self‐care in‐center; £29,866 for hemodialysis provided 3.5× weekly as home self‐care; and £36,185 for hemodialysis provided 3.5× weekly as self‐care in‐center.
Discussion
We found that the SC+ hemodialysis system offers improved cost‐effectiveness for both 3×‐weekly and 3.5×‐weekly self‐care dialysis performed at home or as self‐care in‐center versus fully assisted dialysis provided 3× weekly with conventional machines in facilities.</description><subject>cost effectiveness</subject><subject>Cost-Benefit Analysis</subject><subject>dialysis</subject><subject>economic analysis</subject><subject>hemodialysis</subject><subject>Hemodialysis, Home</subject><subject>Humans</subject><subject>Kidney Failure, Chronic - therapy</subject><subject>Peritoneal Dialysis</subject><subject>Renal Dialysis</subject><subject>Self Care</subject><issn>1492-7535</issn><issn>1542-4758</issn><issn>1542-4758</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><recordid>eNp1kEtOwzAQhi0EolBYcAHkJQiltR3bSZYoPFpRCSTo2nIcmxrl0caJUHYcgTNyEkxT2DHSaGbxzafRD8AZRhPsa7rK7QSTJKF74AgzSgIasXjf7zQhQcRCNgLHzr0hRDBC_BCMQoYQ9n0EntLatbA2sF1puOlk1Ur4nF7BlS7r3Mqid9ZB17tWl9DUDXS6MF8fn0o2Gtpqe7WsbKtz-GCr17wuT8CBkYXTp7s5Bsu725d0Fiwe7-fp9SJQJGI0wKHKeM55FkrGMWYxJUaayP-tMmyQVLnSmmYmCQnxXKQ5VQoxHEdxlDHEwzG4GLzrpt502rWitE7popCVrjsnCMcxQyREzKOXA6qa2rlGG7FubCmbXmAkfgIUPkCxDdCz5zttl5U6_yN_E_PAdADebaH7_01idjMflN8brXmX</recordid><startdate>202207</startdate><enddate>202207</enddate><creator>Ferguson, Thomas W.</creator><creator>Harper, Gerard D.</creator><creator>Milad, John E.</creator><creator>Komenda, Paul V. J.</creator><general>John Wiley & Sons, Inc</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202207</creationdate><title>Cost of the quanta SC+ hemodialysis system for self‐care in the United Kingdom</title><author>Ferguson, Thomas W. ; Harper, Gerard D. ; Milad, John E. ; Komenda, Paul V. J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2754-13cb6d66b3a56115842faf7758cb1f0acdcee4bf93226d67e64cc0518787b5063</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>cost effectiveness</topic><topic>Cost-Benefit Analysis</topic><topic>dialysis</topic><topic>economic analysis</topic><topic>hemodialysis</topic><topic>Hemodialysis, Home</topic><topic>Humans</topic><topic>Kidney Failure, Chronic - therapy</topic><topic>Peritoneal Dialysis</topic><topic>Renal Dialysis</topic><topic>Self Care</topic><toplevel>online_resources</toplevel><creatorcontrib>Ferguson, Thomas W.</creatorcontrib><creatorcontrib>Harper, Gerard D.</creatorcontrib><creatorcontrib>Milad, John E.</creatorcontrib><creatorcontrib>Komenda, Paul V. J.</creatorcontrib><collection>Open Access: Wiley-Blackwell Open Access Journals</collection><collection>Wiley Online Library Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Hemodialysis international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ferguson, Thomas W.</au><au>Harper, Gerard D.</au><au>Milad, John E.</au><au>Komenda, Paul V. J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cost of the quanta SC+ hemodialysis system for self‐care in the United Kingdom</atitle><jtitle>Hemodialysis international</jtitle><addtitle>Hemodial Int</addtitle><date>2022-07</date><risdate>2022</risdate><volume>26</volume><issue>3</issue><spage>287</spage><epage>294</epage><pages>287-294</pages><issn>1492-7535</issn><issn>1542-4758</issn><eissn>1542-4758</eissn><abstract>Introduction
New personal hemodialysis systems, such as the quanta SC+, are being developed; these systems are smaller and simpler to use while providing the clearances of conventional systems. Increasing the uptake of lower‐intensity assistance and full self‐care dialysis may provide economic benefits to the public health payer. In the United Kingdom, most hemodialysis patients currently receive facility‐based dialysis costing more than £36,350 per year including patient transport. As such, we aimed to describe the annual costs of using the SC+ hemodialysis system in the United Kingdom for 3×‐weekly and 3.5×‐weekly dialysis regimens, for self‐care hemodialysis provided both in‐center and at home.
Methods
We applied a cost minimization approach. Costs for human resources, equipment, and consumables were sourced from the dialysis machine developer (Quanta Dialysis Technologies) based upon discussions with dialysis providers. Facility overhead expenses and transport costs were taken from a review of the literature.
Findings
Annual costs associated with the use of the SC+ hemodialysis system were estimated to be £26,642 for hemodialysis provided 3× weekly as home self‐care; £30,235 for hemodialysis provided 3× weekly as self‐care in‐center; £29,866 for hemodialysis provided 3.5× weekly as home self‐care; and £36,185 for hemodialysis provided 3.5× weekly as self‐care in‐center.
Discussion
We found that the SC+ hemodialysis system offers improved cost‐effectiveness for both 3×‐weekly and 3.5×‐weekly self‐care dialysis performed at home or as self‐care in‐center versus fully assisted dialysis provided 3× weekly with conventional machines in facilities.</abstract><cop>Hoboken, USA</cop><pub>John Wiley & Sons, Inc</pub><pmid>35001500</pmid><doi>10.1111/hdi.12994</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1492-7535 |
ispartof | Hemodialysis international, 2022-07, Vol.26 (3), p.287-294 |
issn | 1492-7535 1542-4758 1542-4758 |
language | eng |
recordid | cdi_proquest_miscellaneous_2618502305 |
source | Wiley-Blackwell Read & Publish Collection |
subjects | cost effectiveness Cost-Benefit Analysis dialysis economic analysis hemodialysis Hemodialysis, Home Humans Kidney Failure, Chronic - therapy Peritoneal Dialysis Renal Dialysis Self Care |
title | Cost of the quanta SC+ hemodialysis system for self‐care in the United Kingdom |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T01%3A05%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cost%20of%20the%20quanta%20SC+%20hemodialysis%20system%20for%20self%E2%80%90care%20in%20the%20United%20Kingdom&rft.jtitle=Hemodialysis%20international&rft.au=Ferguson,%20Thomas%20W.&rft.date=2022-07&rft.volume=26&rft.issue=3&rft.spage=287&rft.epage=294&rft.pages=287-294&rft.issn=1492-7535&rft.eissn=1542-4758&rft_id=info:doi/10.1111/hdi.12994&rft_dat=%3Cproquest_cross%3E2618502305%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2754-13cb6d66b3a56115842faf7758cb1f0acdcee4bf93226d67e64cc0518787b5063%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2618502305&rft_id=info:pmid/35001500&rfr_iscdi=true |